SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-192076
Filing Date
2014-05-09
Accepted
2014-05-09 14:12:53
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d707929d10q.htm 10-Q 628255
2 EX-10.1 d707929dex101.htm EX-10.1 15881
3 EX-31.1 d707929dex311.htm EX-31.1 9425
4 EX-31.2 d707929dex312.htm EX-31.2 9446
5 EX-32.1 d707929dex321.htm EX-32.1 4547
6 EX-32.2 d707929dex322.htm EX-32.2 4568
  Complete submission text file 0001193125-14-192076.txt   3687549

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aegr-20140331.xml EX-101.INS 474589
8 XBRL TAXONOMY EXTENSION SCHEMA aegr-20140331.xsd EX-101.SCH 36091
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20140331_cal.xml EX-101.CAL 61289
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20140331_def.xml EX-101.DEF 70784
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20140331_lab.xml EX-101.LAB 273613
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20140331_pre.xml EX-101.PRE 183616
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 14828349
SIC: 2834 Pharmaceutical Preparations